FDA’s First ‘Early Alert’ Under New Communications Pilot Targets Fresenius Infusion Pumps

The US FDA has issued its first communication as part of a new pilot program the agency initiated to increase transparency in recalls of high-risk medical devices. The early alerts are meant to minimize the time between the FDA finding out about a potential issue and informing stakeholders.